Blog

How Timely Expert-Led Education Accelerates Clinical Decision-Making

Physicians make treatment decisions in a narrow window. Learn why timely, peer-to-peer education closes the gap that digital content alone can't reach.

ASCO 2025 Highlights: Critical Advancements in Precision Oncology

Content that Connects: How to work with KOLs to Build HCPs Trust and Influence

Enhance HCP engagement through peer-led content that builds trust and drives prescribing confidence with Diaceutics' innovative strategies and insights.

Diagnostic Pathway Variation: Why Delivery Breaks Before Discovery

Discover how to improve access to diagnostic-driven therapies by addressing delivery challenges and enhancing engagement through real-world insights and targeted solutions.

Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks

Enhance your precision medicine strategy through multi-modal communications and peer engagement, driving effective diagnostic commercialization and maximizing patient outcomes.

Redefining HCP Engagement with Clinical, Behavioral & Companion Diagnostics

Transform HCP engagement by integrating clinical, behavioral, and companion diagnostics data for precise targeting and improved outreach effectiveness. Discover the future of pharma marketing.

D-Cubed Pharma ROI: The $20B Advantage

Discover how the D-Cubed Model transforms pharma ROI through diagnostics, data, and digital strategies, leading to faster drug launches and enhanced patient access.

Linking Rare Disease Patients to Targeted Therapies

Diaceutics connects rare disease patients to targeted therapies through advanced patient identification, improving access to care and accelerating clinical trial enrollment.

ESMO 2025: Top 5 Key Cancer Diagnostics Takeaways From Our Experts

Discover 5 key insights from ESMO 2025 on cancer diagnostics, focusing on ctDNA, antibody-drug conjugates, and innovative strategies for improving patient outcomes in precision medicine.

Precision Over Presence: Why Personalization At Scale Drives Better Patient Engagement

Discover how Diaceutics empowers pharma marketers with data-driven solutions for effective HCP targeting and improved commercial outcomes.

Measuring What Matters: How to Track and Improve HCP Engagement ROI

Discover how to effectively measure HCP engagement ROI, linking marketing efforts to clinical outcomes and improving patient care with innovative strategies and insights.

ASCO 2026 Trends to Watch: Precision Oncology, AI and Real-World Impact

Explore key trends in precision oncology, AI integration, and real-world impact at ASCO 2026, focusing on biomarker-driven therapies and actionable insights for improved patient outcomes.

Navigating the New Amendments to the EU In Vitro Devices Regulation (IVDR)

EU adopts amendments to the In Vitro Devices Regulation, extending compliance deadlines and addressing diagnostic shortages to support manufacturers and ensure availability of essential tools.

Why Commercial Strategy Must Step Up to Unlock Biomarker Testing and Actionability

Unlock the future of oncology with insights on biomarker testing, ADCs, ctDNA, and digital pathology trends shaping your commercial strategy. Stay competitive in precision medicine.

AI in Pharma Marketing, Diagnostics & the Future of Pharma Engagement

Discover how AI and real-time diagnostics data can transform pharma marketing, enhancing HCP engagement and driving better patient outcomes. Explore the future of pharma engagement today.

Q&A: How can a multi-modal approach using lab data simplify precision medicine?

Explore how a multi-modal approach using lab data enhances precision medicine, improving patient outcomes and treatment strategies through actionable insights and better-informed decisions.

Diaceutics x DeepIntent Partnership: Transforming HCP Engagement with Real-Time Diagnostic Solutions and Genomic Audiences

Discover how Diaceutics and DeepIntent enhance HCP engagement with real-time diagnostic solutions, empowering life sciences marketers to optimize campaigns based on dynamic patient data.

From Blockbusters to Biomarkers: Rethinking Commercialization for the Precision Era and the Importance of Diagnostic Testing

Discover how Targeted Commercialization transforms precision medicine by aligning diagnostic testing with therapy launches, ensuring the right patients receive timely treatments.

From Test to Treatment: Closing the Final Mile in Patient Care

Discover how real-time support bridges gaps in patient care, enhancing treatment pathways and outcomes through targeted commercialization and expert engagement in precision medicine.

Levelling Up series Part 2: Precision testing’s suboptimal HTA - Time to level up

Explore the need for improved economic assessments of precision testing to unlock the full potential of precision treatments in healthcare.

HCP Engagement Strategies: 4 Takeaways from Fierce Pharma 2026

Discover key insights from Fierce Pharma Engage 2026 on evolving HCP engagement strategies, emphasizing AI, content relevance, and outcome-based performance measurement for impactful interactions.

Levelling Up series Part 1: Time to level up testing and treatment

Discover how improved testing and treatment integration can enhance patient outcomes in precision medicine, addressing current healthcare inequalities and evolving engagement strategies.

The Clinical Decision Making Window: How Timing Determines Therapy Uptake

Discover how timing influences therapy uptake in diagnostic-driven treatments and learn how targeted engagement can enhance patient outcomes within the clinical decision-making window.

ASCO 2026 Day 3 Highlights: A Transformative Advance in Pancreatic Cancer

Discover groundbreaking advancements in cancer treatment from ASCO 2026, including RAS-targeted therapy for pancreatic cancer and novel approaches for prostate and lung cancers.

Speed to Market Starts Before the Prescription

Discover how Diaceutics and DeepIntent revolutionize pharma marketing by shifting focus to real-time diagnostic intelligence, enhancing engagement before prescriptions are written.

Navigating Precision Medicine Challenges in IMIDs

Explore the challenges of diagnosing and treating immune-mediated inflammatory diseases, and discover how precision medicine can improve patient outcomes and streamline treatment strategies.

What Physicians Need Now: Relevance, Timing and Trust

Physicians need timely, relevant, and trusted information to enhance patient care. Discover solutions that empower informed decision-making in a complex healthcare landscape.

Levelling Up Series Part 3: The Systemic Shadow Hanging Over the Value of Diagnostics

Explore the critical need for improved measurement of diagnostics' value in precision medicine to drive innovation, reimbursement, and patient outcomes in healthcare.

Seamless Diagnostic Testing: 12 Recommendations to Drive Your Launch Strategy to Success

Explore key barriers to seamless diagnostic testing in precision medicine and discover strategies to enhance patient identification and treatment outcomes.

Embracing Precision Medicine: The Heart of Value-Based Care

Discover how Diaceutics advances value-based care through precision medicine, ensuring patients receive tailored treatments supported by robust data integration and innovative solutions.

Unleashing the Potential of the Microbiome in Precision Medicine: A New Frontier for Pharma

Explore how the microbiome is transforming precision medicine, enhancing drug efficacy, and paving the way for innovative therapies in the pharmaceutical industry.

Reigniting Momentum: A Curated Round‑Up of This Season’s Most Impactful Insights

Discover how real-time diagnostic insights and expert-led engagement can rebuild prescriber confidence and reignite brand momentum.